Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
about
Insights into Newer Antimicrobial Agents Against Gram-negative BacteriaCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsThe cell wall amidase AmiB is essential for Pseudomonas aeruginosa cell division, drug resistance and viability.High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.Synergistic combinations of polymyxins.Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections.Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria.Anti-MRSA Activities of Enterocins DD28 and DD93 and Evidences on Their Role in the Inhibition of Biofilm Formation.Legionella Pneumophila and Dendrimers-Mediated Antisense Therapy.Antimicrobial activities of widely consumed herbal teas, alone or in combination with antibiotics: an in vitro study.Synergistic Effect of Doripenem and Cefotaxime to Inhibit CTX-M-15 Type β-Lactamases: Biophysical and Microbiological Views.Bifunctional antimicrobial conjugates and hybrid antimicrobials.No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis.Bacterial spectrum and resistance patterns in corneal infections at a Tertiary Eye Care Center in South China.Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro.The Transient Multidrug Resistance Phenotype of Salmonella enterica Swarming Cells Is Abolished by Sub-inhibitory Concentrations of Antimicrobial Compounds.A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China.Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens.
P2860
Q26751255-613BEBE6-DF7C-4465-8E0D-A13D7D1275D2Q33659230-7812F9B9-3285-467F-ADBF-F080BAD28DE2Q36283107-3E799137-F8B4-4728-BE3A-B0B8129E120EQ36410455-2D0E43F9-1013-4898-A879-64907154CFEBQ37586960-B48696A5-C390-4505-88E4-21A437EAC8D7Q38670032-04FB877E-0DA0-47A0-B58C-9E971CE3B5C4Q38847017-662F5911-33CC-4533-91DF-5C205893235CQ38888005-5AF6FC02-70C9-44C0-A6B2-5AC02B981678Q39682426-1247C95C-2575-43B0-B505-83A2F46F5692Q40111940-1124D2C7-9C29-4672-BA26-6CB339BD4FF6Q40111978-53AD22D2-1822-4FC2-8A36-EB74885CA489Q40127260-540EE924-47E2-473A-9642-35D4008E56C9Q40203926-92D0E6D2-0ECF-4650-9C84-396F01905C38Q40322197-C53DBF60-6731-48FF-B79E-2E21D58CF9A3Q40596352-EC55855B-C43E-4807-80E1-056B2E745CA7Q40668393-F1051100-B415-4B27-ACF3-DE11F8DB5506Q41050631-79221F5B-E4F3-4BE6-9C8F-C7670725BD7BQ42535527-4B5CCCA3-9E0A-45DA-AE39-0C13262354A3Q55266483-17194B02-B5ED-41CC-B52E-9EC8E0C1CAA5Q55432018-E415DDC7-3BB3-4265-9E6B-97CE6BF19B16
P2860
Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
@en
type
label
Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
@en
prefLabel
Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
@en
P2860
P921
P1476
Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.
@en
P2093
Thomas Tängdén
P2860
P304
P356
10.3109/03009734.2014.899279
P5008
P577
2014-03-26T00:00:00Z
2014-05-01T00:00:00Z